NeuroVision   integrated neuroscience company focused  delivering scientifically validated, diagnostic tests & biomarkers   detection  monitoring  amyloid pathology   Alzheimers Disease.   The company  developed   retinal imaging technology,     utilized     clinical trials globally.With access  unique datasets,  provide data aggregation services, analysis, biostatistics,  applications  machine learning algorithms   repositories  images   biomarker data seeking  advance  collective understanding  prediction capabilities  neurodegenerative diseases.
